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Purpose: To determine the effects of vaginal birth after cesarean (VBAC) versus repeated 
cesarean sections (RCS) after a primary cesarean section (CS), on the rate of intraoperative 
and postpartum maternal morbidity.
Patients and methods: This is a retrospective population-based cohort study. During the 
study period (1988–2005) there were 200,012 deliveries by 76,985 women at our medical 
center; 16,365 of them had a primary CS, of which 7429 women delivered a singleton infant 
after the primary CS, met the inclusion criteria, were included in our study, and were followed 
for four consecutive deliveries. Patients were divided into three study groups according to the 
outcome of their consecutive delivery after the primary CS: VBAC (n = 3622), elective CS 
(n = 1910), or an urgent CS (n = 1897). Survival analysis models were used to investigate the 
effect of the urgency of CS and the numbers of pregnancy predating the primary CS on peri-
partum complications.
Results: Women who failed a trial of labor had a higher rate of uterine rupture than those who 
had a VBAC. Patients who delivered by CS had a higher rate of endometritis than those giving 
birth vaginally. The rate of cesarean hysterectomy and transfer to other departments increased 
significantly at the fourth consecutive surgery (P = 0.02 and P = 0.003, respectively). VBAC 
was associated with a 55% reduction in the risk of intrapartum complications in comparison 
to a planned CS (hazard ratio [HR] 0.45; 95% confidence interval [CI]: 0.22–0.89. A greater 
maternal parity at the time of primary CS was associated with lower intrapartum and postpartum 
morbidities (HR 0.44; 95% CI: 0.24–0.79; HR 0.54; 95% CI: 0.47–0.62, respectively).
Conclusions: (1) A successful VBAC is associated with a reduction in the intrapartum com-
plications; and (2) maternal morbidity increases substantially from the fourth consecutive 
cesarean delivery.
Keywords: trial of labor, uterine rupture, hysterectomy, blood transfusion, parity
Introduction
Cesarean section (CS) is the most common surgery performed in the US and its rate 
is progressively rising throughout the world.1 The major increase in the CS rate in 
western societies was recorded between the 1970s and early 1980s. A transient decrease 
in primary CS, along with an increase in vaginal birth after cesarean (VBAC), was 
observed between 1989 and 1996;2 however, since 1996, the total cesarean rate has 
been annually increasing reaching 27.6% in 20033 and 30.1% in 2006.4
Maternal morbidity associated with a CS is substantially higher than that of a 
vaginal delivery.5–7 Therefore, VBAC had been regarded as an effective method to 
reduce the rate of recurrent cesarean deliveries. However, recent studies demonstrated 
higher maternal and fetal complications in patients undergoing a trial of labor after 
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CS than in those electively delivered by an elective repeated 
CS.8–10 Indeed, a symptomatic uterine rupture occurred in 
0.5%–0.7% of women who underwent a trial of labor11 and 
  the rate of hypoxic–ischemic encephalopathy increases 
among patients who attempt a trial of labor especially in 
cases of   uterine rupture during this process.11–14 Because 
of that, the   American College of Obstetrics and Gynecol-
ogy (ACOG), has recommended that a trial of labor after 
cesarean delivery is to be done only in hospitals that have 
facilities for emergency CS. The new guidelines say that 
hospitals ill-equipped for immediate surgery should help 
women find care elsewhere and have a plan to manage 
uterine ruptures.15
Thus far, the data regarding maternal complications 
of deliveries following a CS (either by VBAC or elective 
repetitive CS), has mainly focused on the first birth after 
the primary CS. In contrast, there is a paucity of infor-
mation concerning maternal morbidity associated with 
either repeated VBAC or repeated CS (RCS). The aims of 
this large population cohort study including women with 
a prior CS were to: (1) compare the maternal morbid-
ity associated with elective repetitive CSs and repeated 
VBACs; and (2) compare the maternal morbidity of an 
elective repetitive CS with that of an emergency CS due 
to failed trial of labor.
Materials and methods
Study population and selection  
of patients
This retrospective population-based cohort study included 
7429 women with a singleton pregnancy who delivered sub-
sequently to a primary CS at the Soroka University Medical 
Center, a regional tertiary medical center in Beer Sheva, 
Israel, where all the births in the region take place. Cases 
were identified by searching a computerized birth records 
database. Women included in the study were followed up to 
a maximum of four consecutive deliveries after their primary 
CS in the univariate analyses.
Outcome variables
Data concerning demographic characteristics, medical and 
obstetric history, as well as pregnancy, delivery, and perinatal 
outcome, were obtained from the computerized database. 
The primary outcomes were the rate of intrapartum and 
postpartum maternal complications during consecutive trials 
of labor and the intraoperative and postoperative complica-
tions of patients with repetitive CS. The data were analyzed 
by two methods: (1) the effect of recurrent CSs versus 
repeated VBACs on intrapartum, operative, and postpartum 
complications; and (2) the effect of a failure in trial of labor 
on maternal morbidity.
For patients who attempted a VBAC, intrapartum 
complications included failure to progress during the first 
and second stages of labor, placental abruption, uterine rup-
ture, uterine scar dehiscence, instrumental delivery, blood 
product transfusion, and the need for urgent CS. Postpartum 
complications included postpartum fever, endometritis, uri-
nary tract infection, anemia, uterine rupture, blood product 
transfusion, and transfer to other departments (ie, intensive 
care unit).
For patients who underwent a CS, either elective or urgent, 
intraoperative complications included infection, trauma to 
adjacent organs, hysterectomy, blood products transfusion, 
and transfer to another department after CS. Post-operative 
complications included: reopening of cesarean scar, disrup-
tion of cesarean scar, and wound infection.
Statistical analysis
Maternal demographic characteristics, peripartum com-
plications, and perinatal outcomes were compared with a 
two-step analysis. First, we compared the rate of complica-
tions between patients who underwent repeated VBAC and 
those who had RCSs. Subsequently, we compared the rate of 
complications of elective and urgent CS in patients with RCS 
and in those who failed a trial of VBAC. Student’s t-test was 
used to compare means for normally distributed variables. 
Chi-square and Fisher exact tests were used to compare cat-
egorical variables. Cox proportional hazard regression was 
performed to investigate the association between repeated 
VBAC, maternal parity at primary CS, and urgent versus 
planned CS, to peripartum and postpartum complications. 
A P value of ,0.05 was considered significant. Analysis 
was done using SAS packages (version 9.1; SAS Institute, 
Cary, NC).
Results
During the study period (1988–2005) there were 200,012 
deliveries by 76,985 women at our medical center; 16,365 
of them had a primary CS, of which 7429 women delivered 
a singleton infant after the primary CS, met the inclusion 
criteria, and were included in our study (the indication and 
perinatal complication leading to the primary CS are pre-
sented in Supplementary Table 1). The study population was 
further divided according to the outcome of the subsequent 
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delivery after the primary CS: 48.8% (3622/7429) had a suc-
cessful trial of labor and were included in the VBAC group; 
25.5% (1897/7429) had an urgent CS due to maternal or fetal 
indication and comprised the urgent CS group; and 25.7% 
(1910/7429) who had an elective CS and were included in 
that group.
The rate of trial of labor after a primary CS was 74.3% 
(5519/7429); of these 65.6% (3622/5516) succeeded and 
had a VBAC. The distribution of repeated VBACs, elective 
and urgent cesarean deliveries up to four consecutive deliver-
ies after the primary CS, are presented in Figure 1A–C. The 
proportion of VBAC out of all the deliveries increases with 
each additional consecutive birth, and women in the VBAC 
group had a higher chance of having four consecutive deliver-
ies after the primary CS than women in the urgent CS (odds 
ratio [OR], 2.13; 95%; confidence interval [CI]: 2.43–3.54) 
or the elective CS (OR, 13; 95% CI: 9.16–18.55) groups. 
Of interest is the finding that women included in the urgent 
CS group had a higher chance of having four consecutive 
deliveries after the primary CS than those included in the 
elective CS group (OR, 4.44; 95% CI: 3.03–6.53) (Figure 2). 
Demographic characteristics of the study groups are pre-
sented in Table 1.
The rate of pregnancy and peripartum complications of 
the consecutive deliveries after the primary CS is   presented in 
Supplementary Table 2. Patients with RCS, compared to those 
who had repeated VBACs, had a higher rate of pregnancy 
  complications. A leading indication for repeated urgent CS 
after the primary CS was labor dystocia; this was the indica-
tion for 39.3% of the urgent CSs in the delivery following the 
primary CS. Of interest, the rate of labor dystocia declined 
to about 15% of the subsequent deliveries (Supplementary 
Tables 3–5).
Patients with RCS were more likely to require blood 
products transfusion than patients in the VBAC group. There 
was no difference in the rate of uterine rupture between those 
with RCS and those with consecutive VBACs. The rate of 
these complications did not differ between urgent and elec-
tive CS (Table 2). In the first three subsequent deliveries 
after the primary CS, patients with RCS had higher rates of 
postpartum fever and endometritis than those with consecu-
tive VBACs (Table 3).
In patients undergoing repeated cesarean deliveries, the 
rate of blood products transfusion, trauma to adjacent organs, 
endometritis, postpartum fever, and urinary tract infections 
did not significantly change with the increase in the number of 
recurrent cesarean deliveries. However, the rate of cesarean 
hysterectomy and transfer to other departments increased 
significantly at the fourth consecutive surgery (P = 0.02 and 
P = 0.003, respectively) (Figure 3). The major indications 
for cesarean hysterectomy were uterine rupture and hemor-
rhage. The rate of placenta accrete differed among the study 
group and was highest among the elective CS group 0.73% 
(14/1910), followed by the urgent CS group 0.16% (3/1897), 
and lowest among those who had VBAC 0.08% (3/3622; 
P , 0.001).
The neonatal outcome of the study groups is presented in 
Supplementary Tables 6–8. The rate of 1-minute Apgar score 
,5 was higher among patients with recurrent CS than in those 
with consecutive VBACs in all subsequent   pregnancies fol-
lowing the primary CS. However, the rate of 5-minute Apgar 
score ,7 did not differ significantly between the study groups 
in all the subsequent deliveries after the primary CS. The total 
perinatal mortality rate was higher among women who had a 
VBAC in the first delivery after the primary CS than in those 
with recurrent CS, mainly due to a higher rate of antepartum 
death in the VBAC group. However, in the fourth delivery 
after the primary CS, women with recurrent CS had a higher 
rate of total perinatal mortality than those with repeated 
VBACs, mainly due to a higher rate of postpartum death 
(Supplementary Tables 7 and 8).
The contribution of a failure in a trial of labor to maternal 
morbidity is a key question. In order to address it we further 
analyzed our data including patients who had an urgent 
cesarean delivery due to labor dystocia. In comparison to 
women undergoing a nonurgent CS, those who failed a trial 
of labor had a higher rate of CS complications in general 
(P , 0.001), infections, and the need to transfer to another 
department in the second and third delivery after the primary 
CS (Table 4).
In comparison to those who had a successful VBAC, 
those who failed in a trial of labor had a higher rate of uterine 
rupture (P , 0.001). Of interest, the rate of uterine rupture 
did not differ between those who had a nonurgent CS and 
those who failed a trial of labor (Table 5).
To study the additive effect of RCS versus subsequent 
VBACs we constructed a Cox proportional hazard model sep-
arately for intrapartum and postpartum maternal   morbidity, in 
which the outcome of nonurgent repeated morning CS served 
as the reference point and was compared to the outcome 
of VBAC and urgent CS at each consecutive delivery. The 
number of deliveries after the primary CS served as the time 
parameter. In the model for intrapartum complications, a 
protective effect was given by any additional VBAC (HR, 
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Figure 1 Mode of delivery in consecutive deliveries after the primary CS of patients who had a (A) VABC, (B) urgent CS, or (C) elective CS.
Abbreviations: CS, cesarean section; VBAC, vaginal birth after cesarean.
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0.45; 95% CI: 0.22–0.9) and by maternal parity at primary CS 
(HR, 0.44; 95% CI: 0.24–0.79) (Table 6a). Urgent CS was not 
associated with a significant change in the risk of intrapartum 
complications versus nonurgent repeated morning CS. In 
the model for maternal postpartum morbidity, only maternal 
parity at primary CS had a significant protective effect (HR, 
0.54; 95% CI: 0.47–0.62) (Table 6a). The introduction of 
maternal age and labor dystocia to the model did not affect 
its results (Table 6b).
Discussion 
Principal findings of the study
A successful trial of labor after a primary CS is associated 
with a higher future parity. In comparison to those who 
delivered by RCS in all subsequent pregnancies, patients 
who delivered consecutively by repeated VBACs had a 
lower maternal morbidity, and a 51.9% reduction in the 
risk of intrapartum complications for each successful trial 
of labor. A failure in a trial of labor is a major cause of 
maternal morbidity, mainly in the first delivery after the 
primary CS.
What is the effect of repeated VBACs 
versus recurrent CS
The finding that repeated trials of labor ending in successful 
VBACs are associated with lower maternal morbidity than 
RCS is novel. This study is the first to compare the outcome of 
consecutive VBAC to RCSs. Indeed, women who underwent 
repeated vaginal deliveries after the primary CS had lower 
rate of blood products transfusion and postpartum infections 
than women who had repeated cesareans. The finding that 
each additional VBAC, when compared to elective RCS, was 
associated with a 55% reduction in the risk for intrapartu-
mand postpartum complication in comparison to elective CS, 
is novel and further emphasizes the safety and the benefit of 
a successful trial of labor.
Repeated VBACs were associated with an overall reduc-
tion in intrapartum and postpartum maternal morbidity with 
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Figure 2 The rate of VBAC, urgent CS and elective CS in the subsequent deliveries after the primary CS.
Abbreviations: CS, cesarean section; VBAC, vaginal birth after cesarean.
Table 1 Demographic characteristics of patients at subsequent pregnancy after primary cesarean delivery according to the route of 
delivery
Measure VBAC (n = 3622) Elective CS (n = 1910) Urgent CS (1897) P-value
Jewish origin 43.4% (1572/3622) 70.6% (1348/1910) 48.2% (914/1897) ,0.001
Age (years)
  Mean ± SD (n) 28.15 ± 5.42(3621) 31.34 ± 5.21(1906) 29.70 ± 5.56(1895) ,0.001
Gravidity
  2–5 76.4% (2764/3616) 74.1% (1416/1910) 74.5% (1413/1896) 0.1046
 6 + 23.6% (852/3616) 25.9% (494/1910) 25.5% (483/1896)
Parity
  2–5 86.4% (2928/3387) 87.1% (1565/1796) 85.1% (1525/1793) 0.1760
 6 + 13.6% (459/3387) 12.9% (231/1796) 14.9% (268/1793)
Infertility treatments 6.9% (251/3622) 7.5% (143/1910) 7.2% (136/1897) 0.7444
Note: Data is presented in percentage (number).
Abbreviations: VBAC, vaginal birth after cesarean; CS, cesarean section. 
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every additional delivery. This is in accord with the findings 
of Mercer et al,16 who reported that among 13,532 women 
from 19 medical centers across the US, VBAC success 
increased with increasing number of prior VBACs. The 
rate of uterine rupture decreased after the first successful 
VBAC and did not increase thereafter. The risk of uterine 
dehiscence and other peripartum complications also declined 
substantially after the first successful VBAC. In comparison 
to the findings of this group, we had a lower rate of uterine 
rupture in every additional VBAC, and a somewhat lower rate 
of successful VBAC in each consecutive delivery. The main 
explanation for this observation is that some of the centers 
included in the study of Mercer et al16 allowed patients with 
more than one CS to go into a trial of labor, while in our 
center more than one CS is a contraindication for a trial of 
labor. Collectively, our findings and those of others support 
the protective and positive effect of recurrent VBAC on 
maternal morbidity.
In contrast to the beneficial effect of recurrent VBAC, 
repeated cesarean deliveries are associated with increased 
maternal morbidity. We report herein that the rate of 
uterine rupture, hysterectomy, blood and blood product 
transfusion, and the need for transferring the patient to other 
departments rises with the increasing number of cesarean 
deliveries, especially after the fourth consecutive CS. This 
is in accord with previous reports: Makoha et al17 noted 
similar elevation maternal morbidity, including placenta 
previa, placenta accreta, hysterectomy, adhesions, bladder 
injury, postoperative hemoglobin deficit, and need for 
blood transfusion with  an increasing number of cesarean 
deliveries; and Silver et al,18 for the National Institute of 
Child Health and Human Development Maternal-Fetal 
Medicine Units Network, reported that the risks of placenta 
accreta, cystotomy, bowel injury, ureteral injury, and ileus, 
the need for postoperative ventilation, intensive care unit 
admission, hysterectomy, and blood transfusion requiring 
four or more units, and the duration of operative time and 
hospital stay, significantly increased with an increasing 
number of cesarean deliveries. Similarly to our findings, 
Silver et al18 reported that there was a substantial increase 
in the risk for several morbidities, including placenta 
accreta, cystotomy, and need for hysterectomy or intensive 
care unit admission with the fourth or greater cesarean 
delivery. Thus, although there is no strict cut off regarding 
the number of consecutive CSs, it seems that the maternal 
risk for serious intraoperative complications increases 
substantially from the fourth RCS. This information should 
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be included while counseling patients regarding repeated 
cesarean births.
An additional effect of repeated VBACs is the higher 
number of subsequent deliveries after the primary CS in 
comparison to those of women who had an elective or 
urgent RCS. Of interest is the fact that a higher proportion 
of those who underwent an urgent CS, immediately after the 
primary CS, had four subsequent pregnancies in compari-
son to those who had an elective CS. This finding is novel, 
and it may reflect the differences in the study population; 
meaning that a higher proportion of patients who choose 
to have an elective cesarean after the primary CS have a 
tendency to smaller families than those who attempt a trial 
of labor after the primary CS. Indeed, the sharp decline 
in the number of deliveries in this group is after the third 
cesarean. Guise et al19 proposed that a woman’s decision 
to undergo a trial of labor after a primary CS is a complex 
process that is affected by medical, cultural, behavioral, 
and legal factors. The retrospective nature of our study 
does not allow us a deeper and more thorough investigation 
into these factors in relation to our population. A specially 
designed prospective study will need to be conducted in 
order to address the effect of these factors on the patient’s 
decision to undergo a trial of labor versus elective CS; 
nevertheless, educating women about their options early 
enough in pregnancy for them to make an informed choice 
is a key factor in this process.
What is the effect of labor dystocia on the success 
of a trial of labor?
The success of a trial of labor is an end point of many 
variables. Some of these parameters have been included 
in different prediction models20–23 aiming to assess the 
probability of a given patient to deliver vaginally after 
a primary CS. According to our findings, labor dystocia 
is a significant contributor to a failure of a trial of labor 
mainly in the first delivery after a primary CS. Dystocia 
was the indication for almost 40% of the urgent CS in the 
delivery following the primary CS, yet in the subsequent 
deliveries, its rate declined to about 15% of the urgent CS. 
This finding further emphasizes previously published data 
that women with a history of a labor dystocia which led to 
their primary CS have a lower chance to succeed in a trial of 
labor in the subsequent birth.24–27 In addition, our finding that 
the rate of dystocia as an indication for urgent CS declines 
in the following deliveries suggests that women who twice 
failed a trial of labor probably deliver by elective CS in 
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their subsequent pregnancies or stop delivering. Indeed, in 
our cohort, only 45.9% of women who had an urgent CS 
during the subsequent birth after the primary cesarean had 
additional deliveries, mostly by elective CS. In contrast to 
this group, 60.9% of women who had a successful VBAC 
after the primary CS continued to deliver and only 8.4% of 
them had an elective CS. Collectively the data presented 
herein suggest that the success in vaginal delivery at 
the subsequent birth after the primary CS has important 
implication for maternals health and reproductive future. 
Those who prevail in the trial of labor and have a VBAC 
will have overall higher pregnancy rate and lower maternal 
morbidity than those who failed a trial of labor and women 
who chooses elective RCS.
Strength and limitation of the study
The limitation of this study is its retrospective nature and 
the fact that the data are derived from a database which has 
inherited limitations. Moreover, in the analysis of the data 
it seems that the inclination of the medical team is to go for 
a RCS whenever the patient has an additional pregnancy 
complication aside from the previous CS, which may lead to 
a bias towards allowing a trial of labor only for the healthier 
women. We could not ascertain this bias; nevertheless, the 
large number of deliveries included in our study over such 
a long period, as well as the fact that all the deliveries of 
our region take place at our medical center, assure us that 
the data presented herein is a representative sample of our 
obstetric population.
3
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Infection
CS * 2 (n = 3807) CS * 3 (n = 1387) CS * 4 (n = 504) CS * 5 (n = 168)
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departments
P = 0.8
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P = 0.02
P = 0.008
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Figure 3 Intraoperative complications of patients with recurrent CS.
Abbreviation: CS, cesarean section.
Table 4 Intraoperative complications of patients who failed a trial of labor and those who had a  nonurgent CS
Complications 2nd delivery after index CS 3rd delivery after index CS
Failed TOL 
(n = 105)
Nonurgent CS 
(n = 1186)
P-value Failed TOL 
(n = 46)
Nonurgent CS 
(n = 596)
P-value
Any CS complications 3.8 (4) 1.8 (21) 0.139 6.5 (3) 2.4 (14) 0.115
Infection 1.9 (2) 0.7 (8) 0.192 2.2 (1) 0.8 (5) 0.361
Trauma to adjacent organs 0 0.3 (3) 1.000 2.2 (1) 0.3 (2) 0.200
Hysterectomy 1.0 (1) 0.5 (6) 0.449 4.4 (2) 0.7 (4) 0.063
Blood products transfusion 1.0 (1) 0.3 (4) 0.346 2.2 (1) 0.7 (4) 0.311
Transfer to other department 0 0.5 (6) 1.000 2.2 (1) 0.5 (3) 0.258
Notes: Data is presented in percentage (n). Failed TOL was defined as not-planned CS with labor dystocia.  Nonurgent CS was defined as CS without indication for 
urgent CS when section is performed between 8am–3pm.
Abbreviations: CS, cesarean section; TOL, trial of labor. 
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Conclusion
In summary, repeated VBACS are associated with a lower 
intrapartum maternal morbidity than planned recurrent cesar-
ean deliveries. The recently published National Institute of 
Child Health and Human Development (Bethesda, MD) con-
sensus regarding VBAC, states that about 30% of maternal 
fetal medicine fellows do not consult patients with a previous 
CS regarding the possibility of a trial of labor.2 The findings 
of the current study and others may be used to reduce this 
trend among obstetricians and increase the rate of trial of 
labor. Moreover, the findings of this study further emphasize 
the point that a woman who desires large families should be 
offered a trial of labor after her primary cesarean delivery, 
especially if she had vaginal deliveries prior to her CS.
Supplementary clinical definitions
Parity groups were defined as follows: multipara (two to 
five deliveries) and grand-multipara (six or more deliveries). 
Hypertension was defined in the presence of blood 
  pressure $140/90 mmHg recorded in two separate measure-
ments at least 4 hours apart. Mild hypertension was defined 
as a diastolic blood pressure $90 mmHg and ,110 mmHg 
and/or systolic blood pressure $140 mmHg and ,160 mmHg. 
Severe hypertension was defined in the presence of 
diastolic blood pressure $110 mmHg and systolic blood 
pressure $160 mmHg. Gestational hypertension was defined 
in the presence of hypertension developed after 20 weeks of 
gestation without proteinuria. Preeclampsia was diagnosed in 
the presence of elevated blood pressure and proteinuria of at 
least + 1 in dipstick; its severity was defined according to the 
severity of hypertension and/or one of the following + 3 pro-
teinuria by dipstick, thrombocytopenia #100,000, elevated 
liver enzymes, persistent headache and/or blurred vision.28 
Gestational diabetes was diagnosed according to oral glucose 
tolerance test and was classified according to White’s classi-
fication.29 Hydramnios (amniotic fluid index [AFI]) . 25 cm 
or when a vertical pocket of at least 8 cm was measured or as 
a subjective estimation of increased amniotic fluid volume. 
Oligohydramnios (AFI) ,5 cm, a real-time scanner equipped 
with a 3.5/5 MHz transducer of appropriate focal length esti-
mated amniotic fluid volume. Preterm delivery was defined 
as delivery before completion of 37 weeks of gestation.
Newborns were classified according to their weight as: 
small for gestational age (SGA), birthweight less than the 
10th percentile; adequate for gestational age (AGA), birth-
weight from 10th–90th percentile; and large for gestational 
age (LGA), birthweight .90th percentile according to 
regional growth curves.30 Prelabor rupture of membranes 
Table 6a Cox proportional hazard ratio for factors associated with intra-partum and post-partum complications
Variable Intra-partum complications Post-partum complications
Parameter 
Estimate
Hazard 
Ratio
95% Confidence 
interval
Parameter 
Estimate
Hazard 
Ratio
95% Confidence 
interval
VBAC -0.807 0.45 0.22; 0.90 -0.044 0.96 0.78; 1.18
Unplanned cesarean delivery -0.110 0.90 0.44; 1.83 0.117 1.12 0.88; 1.43
First CS 0.829 0.44 0.24; 0.79 -0.622 0.54 0.47; 0.62
Note: VBAC and unplanned cesarean delivery are compared to planned cesarean delivery.
Abbreviations: First CS, the pregnancy number in which the patient undergoes cesarean delivery; CS, cesarean section; VBAC, vaginal birth after cesarean section.
Table 5 Delivery-related complications of patients who failed a trial of labor, those who had a  nonurgent CS and those who had a VBAC
Complications 2nd delivery after index CS 3rd delivery after index CS
Failed TOL   
(n = 105)
 Nonurgent CS   
(n = 1186)
VBAC  
(n = 1765)
P-value Failed TOL   
(n = 46)
 Nonurgent CS  
(n = 596)
VBAC 
(n = 912)
P-value
Any delivery 
complications
4.8 (5) 3.6 (43) 0.1 (1) ,0.001 2.2 (1) 4.2 (25) 0.2 (2) ,0.001
Dehiscence 1.9 (2) 3.2 (38) 0 ,0.001 0 3.4 (20) 0.2 (2) ,0.001
Blood products 
transfusion
1.0 (1) 0.3 (4) 0 0.010 2.2 (1) 0.7 (4) 0 0.008
Uterine rupture 2.9 (3) 0.2 (2) 0.1 (1) ,0.001 2.2 (1) 0.3 (2) 0 0.016
Notes: Data is presented in percentage. Failed TOL was defined as not-planned CS with labor dystocia;  Nonurgent CS was defined as CS without indication for urgent CS 
when section is performed between 8am–3pm.
Abbreviations: CS, cesarean section; TOL, trial of labor. 
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(PROM) was defined as rupture of the chorioamniotic 
membranes before the onset of labor. Uterine rupture was 
defined as a complete tear of the uterine wall, including 
the visceral peritoneum with establishment of a direct 
communication between the uterine and abdominal cavi-
ties. Dehiscence was defined as an opening of the previous 
cesarean scar with intact visceral peritoneum and no direct 
communication between the uterine and abdominal cavi-
ties. Postpartum fever was defined as maternal temperature 
$38°C, which developed at least 24 hours after delivery 
recorded in two different measurements at least 4 hours apart 
or one measurement of maternal temperature of $38.5°C 
regardless of the time after delivery. Endometritis was 
defined as postpartum maternal fever with clinical signs 
of tenderness above the uterine fundus or during cervical 
manipulation, foul vaginal discharge and positive endo-
metrial culture. Wound infection was defined according to 
either clinical signs of infection or positive wound culture. 
Wound dehiscence was defined as spontaneous opening of 
CS wound including the abdominal fascia.
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Supplementary Table
Table S1 Indications and perinatal complications for primary CS
Measure Rate
Preeclampsia 10.8% (802/7429)
GDM class A 6.4% (474/7429)
GDM class B-R 2.3% (169/7429)
Hydramnios 7.2% (536/7429)
Olihydramnios 6.0% (536/7429)
PROM 9.3% (689/3622)
Mal presentation 33.2% (2467/7429)
Preterm delivery 17.5% (1299/7429)
PPROM 2.5% (183/7429)
Arrest of 1st stage of labor 18.8% (1393/7429)
Arrest of 2nd stage of labor 5.6% (415/7429)
NRFHR 21.2% (1571/7429)
Prolapse of cord 3.6% (269/7429)
Placenta previa 3.1% (229/7429)
Uterine rupture 0.2% (12/7429)
Abbreviations: GDM, gestational diabetes; PROM, prelabor rupture of membranes; 
PPROM, preterm prelabor rupture of membranes; NRFHR, non reassuring fetal 
heart rate.
Table S2 Peri-partum complications in the first delivery after primary CS
Measure VBAC 
(N = 3622)
Elective CS 
(N = 1910)
Urgent CS 
(N = 1897)
P-value
Mild PET 3.0% (108/3622) 3.7% (70/1910) 5.2% (98/1897) 0.0002
Severe PET 0.8% (28/3622) 0.0% (0/1910) 5.6% (107/1897) ,0.0001
Chronic hypertension 1.8% (66/3622) 4.5% (86/1910) 5.2% (99/1897) ,0.0001
GDM class A 4.9% (179/3622) 10.4% (198/1910) 8.9% (168/1897) ,0.0001
GDM class B-R 1.3% (46/3622) 4.8% (92/1910) 4.0% (75/1897) ,0.0001
Hydramnios 3.7% (135/3622) 8.8% (168/1910) 8.9% (169/1897) ,0.0001
Olihydramnios 2.3% (83/3622) 3.0% (58/1910) 4.2% (80/1897) 0.0003
PROM 7.2% (262/3622) 4.5% (85/1910) 9.8% (186/1897) ,0.0001
Mal presentation 1.4% (49/3622) 18.1% (345/1910) 12.4% (235/1897) ,0.0001
Preterm delivery 8.3% (300/3622) 10.1% (192/1910) 14.1% (268/1896) ,0.0001
PPROM 1.2% (45/3622) 0.8% (16/1910) 1.6% (30/1897) 0.1125
Arrest of 1st stage of labor 0.4% (14/3622) 0.0% (0/1910) 33.2% (630/1897) ,0.0001
Arrest of 2nd stage of labor 3.6% (129/3622) 0.0% (0/1910) 6.1% (116/1897) ,0.0001
Arrest of 1st or 2nd stage of labor 3.9% (143/3622) 0.0% (0/1910) 39.3% (746/1897) ,0.0001
NRFHR 2.2% (80/3622) 0.0% (0/1910) 12.1% (229/1897) ,0.0001
Prolapse of cord 0.2% (6/3622) 0.0% (0/1910) 2.2% (42/1897) ,0.0001
Placenta previa 0.1% (4/3622) 2.6% (50/1910) 1.2% (22/1897) ,0.0001
Uterine rupture 0.1% (3/3622) 0.3% (5/1910) 0.3% (5/1897) 0.1793
Abbreviations: PET, preeclampsia; GDM, gestational diabetes; PROM, prelabor rupture of membranes; PPROM, preterm prelabor rupture of membranes; NRFHR,   
non reassuring fetal heart rate.
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Table S3 Peri-partum complications in the second delivery after primary CS
Measure VBAC 
(N = 1765)
Elective CS 
(N = 1186)
Urgent CS 
(N = 685)
P-value
Mild PET 2.4% (42/1765) 1.9% (23/1186) 2.8% (19/685) 0.4934
Severe PET 0.6% (10/1765) 0.0% (0/1186) 7.2% (49/685) ,0.0001
Chronic hypertension 1.8% (32/1765) 4.5% (53/1186) 5.7% (39/685) ,0.0001
GDM class A 4.1% (72/1765) 8.9% (105/1186) 9.1% (62/685) ,0.0001
GDM class B-R 1.2% (21/1765) 4.0% (48/1186) 3.6% (25/685) ,0.0001
Hydramnios 3.6% (64/1765) 8.3% (99/1186) 7.9% (54/685) ,0.0001
Olihydramnios 2.2% (39/1765) 2.2% (26/1186) 3.5% (24/685) 0.1393
PROM 6.7% (118/1765) 1.5% (18/1186) 9.5% (65/685) ,0.0001
Mal presentation 1.3% (23/1765) 11.8% (140/1186) 14.6% (100/685) ,0.0001
Preterm delivery 7.6% (135/1765) 14.1% (167/1186) 26.0% (178/685) ,0.0001
PPROM 1.1% (20/1765) 0.6% (7/1186) 3.2% (22/685) ,0.0001
Arrest of 1st stage of labor 0.1% (2/1765) 0.0% (0/1186) 11.5% (79/685) ,0.0001
Arrest of 2nd stage of labor 1.2% (21/1765) 0.0% (0/1186) 3.1% (21/685) ,0.0001
Arrest of 1st or 2nd stage of labor 1.3% (23/1765) 0.0% (0/1186) 14.6% (100/685) ,0.0001
NRFHR 1.4% (25/1765) 0.0% (0/1186) 8.5% (58/685) ,0.0001
Prolapse of cord 0.2% (3/1765) 0.0% (0/1186) 2.2% (15/685) ,0.0001
Placenta previa 0.0% (0/1765) 2.3% (27/1186) 1.3% (9/685) ,0.0001
Uterine rupture 0.1% (1/1765) 0.2% (2/1186) 0.6% (4/685) 0.0274
Abbreviations: PET, preeclampsia; GDM, gestational diabetes; PROM, prelabor rupture of membranes; PPROM, preterm prelabor rupture of membranes; NRFHR, non 
reassuring fetal heart rate.
Table S4 Peri-partum complications in the third delivery after primary CS
Measure VBAC 
(N = 912)
Elective CS 
(N = 596)
Urgent CS 
(N = 284)
P-value
Mild PET 2.5% (23/912) 1.7% (10/596) 1.8% (5/284) 0.4848
Severe PET 0.7% (6/912) 0.0% (0/596) 9.2% (26/284) ,0.0001
Chronic hypertension 1.3% (12/912) 4.2% (25/596) 5.3% (15/284) 0.0002
GDM class A 5.3% (48/912) 9.2% (55/596) 8.8% (25/284) 0.0069
GDM class B-R 1.3% (12/912) 3.7% (22/596) 4.2% (12/284) 0.0027
Hydramnios 4.4% (40/912) 7.6% (45/596) 8.8% (25/284) 0.0055
Olihydramnios 2.4% (22/912) 2.0% (12/596) 3.5% (10/284) 0.3985
PROM 4.2% (38/912) 2.9% (17/596) 4.9% (14/284) 0.2537
Mal presentation 1.4% (13/912) 13.3% (79/596) 18.0% (51/284) ,0.0001
Preterm delivery 5.0% (46/912) 18.5% (110/596) 30.3% (86/284) ,0.0001
PPROM 0.2% (2/912) 0.8% (5/596) 1.4% (4/284) 0.0561
Arrest of 1st stage of labor 0.0% (0/912) 0.0% (0/596) 14.1% (40/284) ,0.0001
Arrest of 2nd stage of labor 0.8% (7/912) 0.0% (0/596) 1.1% (3/284) 0.0694
Arrest of 1st or 2nd stage of labor 0.8% (7/912) 0.0% (0/596) 15.1% (43/284) ,0.0001
NRFHR 1.2% (11/912) 0.0% (0/596) 4.2% (12/284) ,0.0001
Prolapse of cord 0.0% (0/912) 0.0% (0/596) 1.8% (5/284) ,0.0001
Placenta previa 0.1% (1/912) 1.7% (10/596) 0.4% (1/284) 0.0010
Uterine rupture 0.0% (0/912) 0.3% (2/596) 0.7% (2/284) 0.0697
Abbreviations: PET, preeclampsia; GDM, gestational diabetes; PROM, prelabor rupture of membranes; PPROM, preterm prelabor rupture of membranes; NRFHR, non 
reassuring fetal heart rate.
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Table S5 Peri-partum complications in the fourth delivery after primary CS
Measure VBAC 
(N = 514)
Elective CS 
(N = 256)
Urgent CS 
(N = 156)
P-value
Mild PET 3.3% (17/514) 0.4% (1/256) 1.9% (3/156) 0.0358
Severe PET 0.6% (3/514) 0.0% (0/256) 6.4% (10/156) ,0.0001
Chronic hypertension 1.6% (8/514) 3.1% (8/256) 5.8% (9/156) 0.0155
GDM class A 5.1% (26/514) 6.6% (17/256) 5.8% (9/156) 0.6651
GDM class B-R 1.4% (7/514) 4.7% (12/256) 3.2% (5/156) 0.0206
Hydramnios 2.1% (11/514) 5.1% (13/256) 7.7% (12/156) 0.0037
Olihydramnios 1.4% (7/514) 0.4% (1/256) 1.9% (3/156) 0.3267
PROM 6.8% (35/514) 2.3% (6/256) 6.4% (10/156) 0.0327
Mal presentation 1.4% (7/514) 11.3% (29/256) 13.5% (21/156) ,0.0001
Preterm delivery 7.6% (39/514) 27.0% (69/256) 24.4% (38/156) ,0.0001
PPROM 1.8% (9/514) 0.8% (2/256) 1.9% (3/156) 0.5241
Arrest of 1st stage of labor 0.0% (0/514) 0.0% (0/256) 13.5% (21/156) ,0.0001
Arrest of 2nd stage of labor 0.6% (3/514) 0.0% (0/256) 1.9% (3/156) 0.0595
Arrest of 1st or 2nd stage of labor 0.6% (3/514) 0.0% (0/256) 15.4% (24/156) ,0.0001
NRFHR 1.6% (8/514) 0.0% (0/256) 8.3% (13/156) ,0.0001
Prolapse of cord 0.2% (1/514) 0.0% (0/256) 2.6% (4/156) 0.0007
Placenta previa 0.0% (0/514) 2.3% (6/256) 1.3% (2/156) 0.0034
Uterine rupture 0.0% (0/514) 1.6% (4/256) 0.6% (1/156) 0.0202
Abbreviations: PET, preeclampsia; GDM, gestational diabetes; PROM, prelabor rupture of membranes; PPROM, preterm prelabor rupture of membranes; NRFHR, non 
reassuring fetal heart rate.
Table S6 Perinatal outcome of first delivery after primary cesarean delivery according to the route of delivery
Measure VBAC N = 3622 CS N = 3807 P-value
Male fetus 49.9% (1806/3622) 53.0% (2019/3807) 0.007
SGA 7.4% (267/3622) 6.1% (231/3807) 0.026
LGA 8.3% (301/3622) 17.7% (674/3807) ,0.001
APD 2.0% (73/3622) 0.4% (15/3807) ,0.001
IPD 0.1% (5/3622) 0.0% (1/3807) 0.116
PPD 0.6% (21/3622) 0.8% (32/3807) 0.215
1 minutes Apgar  
score ,5
5.1% (186/3622) 13.2% (502/3807) ,0.001
5 minutes Apgar  
score ,7
3.7% (135/3622) 3.7% (142/3807) 1.000
Birth weight(grams) mean ± SD 3129.2 ± 569.0 3176.7 ± 641.3 ,0.001
Birth weight (grams)
,1500 2.3% (82/3622) 1.9% (74/3807) ,0.001
1500–2500 6.7% (243/3622) 9.7% (368/3807)
.2500 91.0% (3297/3622) 88.4% (3365/3807)
Gestational age at delivery (weeks)
,28 1.0% (38/3622) 0.5% (19/3807) ,0.001
28–32 1.0% (37/3622) 1.5% (59/3807)
32–37 6.1% (220/3622) 9.7% (369/3807)
.37 91.9% (3327/3622) 88.3% (3360/3807)
Abbreviations: SGA, small for gestational age; LGA, large for gestational age; APD, ante partum death; IPD, intrapartum death; PPD, postpartum death.
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Table S7 Neonatal complications in patients with consecutive CS
Complications CS*2 (n = 3807) CS*3 (n = 1387) CS*4 (n = 504) CS*5 (n = 168)
APD 15 (0.4%) 18 (1.1%) 0 2 (1.2%)
PPD 32 (0.8%) 1 (0.6%) 4 (0.8%) 6 (3.6%)
IPD 1 (0.03%) 1 (0.1%) 0 0
All mortality 48 (1.3%) 27 (2.0%) 4 (0.8%) 8 (4.8%)
Apgar score at 1 minute ,5 502 (13.2%) 140 (10.1%) 43 (8.5%) 26 (15.5%)
Apgar score at 5 minutes ,7 142 (3.7%) 51 (3.7%) 12 (2.4%) 14 (8.3%)
Birthweight 3176.7 ± 641.3 3021.4 ± 596.0 2952.5 ± 538.9 2903.4 ± 510.4
SGA 231 (6.1%) 81 (5.8%) 28 (5.6%) 11 (6.6%)
LGA 674 (17.7%) 210 (15.1%) 58 (11.5%) 19 (11.3%)
Gestational age at delivery (mean ± S.D.) 38.5 ± 2.5 37.5 ± 2.1 37.2 ± 2.1 36.8  ± 3.1
Abbreviations: SGA, small for gestational age; LGA, large for gestational age; APD, ante partum death; IPD, intrapartum death; PPD, postpartum death; S.D., standard 
deviation.
Table S8 Neonatal complications in patients with consecutive VBAC
Complications VBAC*2 (n = 3622) VBAC *3 (n = 1721) VBAC *4 (n = 881) VBAC *5 (n = 506)
APD 73 (2.0%) 9 (0.7%) 9 (1.0%) 5 (1.0%)
PPD 21 (0.8%) 11 (0.6%) 4 (0.5%) 0
IPD 5 (0.1%) 1 (0.1%) 1 (0.1%) 0
All mortality 99 (2.7%) 31 (1.8%) 14 (1.6%) 5 (1.0%)
Apgar score at 1 minute ,5 186 (5.4%) 70 (4.1%) 36 (4.1%) 27 (5.3%)
Apgar score at 5 minutes ,7 135 (3.7%) 61 (3.5%) 30 (3.4%) 24 (4.7%)
Birthweight 3129.2 ± 569.0 3187.0 ± 541.0 3215.9 ± 510.2 3224.0 ± 518.0
SGA 267 (7.4%) 114 (6.6%) 61 (6.9%) 39 (7.7%)
LGA 301 (8.3%) 189 (11.0%) 92 (10.4%) 72 (14.2%)
Gestational age at delivery (mean ± S.D.) 39.1 ± 2.5 39.3 ± 2.3 39.5 ± 2.0 39.4 ± 2.1
Abbreviations: SGA, small for gestational age; LGA, large for gestational age; APD, ante partum death; IPD, intrapartum death; PPD, postpartum death; S.D., standard 
deviation.
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